GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » Accounts Payable & Accrued Expense

Wockhardt (BOM:532300) Accounts Payable & Accrued Expense : ₹0 Mil (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Wockhardt Accounts Payable & Accrued Expense?

Wockhardt's quarterly accounts payable & accrued expense increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹9,620 Mil) but then declined from Mar. 2024 (₹9,620 Mil) to Jun. 2024 (₹0 Mil).

Wockhardt's annual accounts payable & accrued expense increased from Mar. 2022 (₹11,330 Mil) to Mar. 2023 (₹11,980 Mil) but then declined from Mar. 2023 (₹11,980 Mil) to Mar. 2024 (₹9,620 Mil).

Wockhardt Accounts Payable & Accrued Expense Historical Data

The historical data trend for Wockhardt's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wockhardt Accounts Payable & Accrued Expense Chart

Wockhardt Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,343.40 9,360.00 11,330.00 11,980.00 9,620.00

Wockhardt Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 8,140.00 - 9,620.00 -

Wockhardt Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Wockhardt Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
BOM:506690 BOM:524735 BOM:532612 BOM:530549 BOM:543748 BOM:509079 BOM:512529 BOM:524164 BOM:524372 NSE:RPGLIFE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
WOCKPHARMA:India
Address
Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Website
http://www.wockhardt.com
Wockhardt Ltd is a major drug manufacturing company with a focus on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in China, Japan, and Russia. The company's strategy includes the use of acquisitions, strategic partnerships, and contract manufacturing.

Wockhardt Headlines

No Headlines